Sensill™ is an AI-driven platform that detects and quantifies, volatile organic compounds (VOCs) across biological and environmental sources in real time.
Initial companion diagnostic applications include immediate, point-of-care infection detection from urine and skin samples, delivered through our scalable pipeline.
- Broad-spectrum antibiotics are nonspecific & can be ineffective or even harmful.
- Waiting for the lab test results gives the infection time to worsen, increasing patient length of stay & costing the healthcare system millions each year.
At Sensill™, we are developing a novel, breakthrough technology to diagnose infections rapidly & noninvasively, in real time—while also making diagnoses quantitative & inexpensive.
- With traditional techniques, identifying infectious microorganisms can take days, forcing patients to wait before they can receive their targeted antibiotics.
- Sensill technology will aim to rapidly (non-invasively, at the point of care) identify & quantify infectious microorganisms (bacteria or fungi) so the appropriate medication can be prescribed immediately after the initial diagnosis plus response to treatment can be monitored continuously until the infection has resolved.
Sensill analyzes volatile organic compounds in order to identify & quantify microorganisms.
Volatile organic compounds (VOCs) are emitted by all bacteria & fungi, each species having a signature combination of VOCs.
The olfactory systems of dogs are highly sensitive to VOCs, enabling them to detect anything from explosives & drugs to cancer & infection. An analogous technological approach can be used to assist doctors in detecting the same VOCs
Sensill is developing patented technology to identify specific microorganisms by their unique combinations of volatile organic compounds (VOCs).
Sensill is innovating technology to detect VOCs with a proprietary, noninvasive, point-of-care technology.
The Sensill™
Diagnostic System
Sensill is developing a diagnostic system that will allow doctors to rapidly & noninvasively diagnose skin and wound as well as urine infections, plus monitor the response to therapy at the point of care.
Get in touch
Tour our site & contact us through our web form to get in touch. Feel free to learn more about our team on the about us page!
Sensill: Redefining Diagnostics.
Sensill is developing a diagnostic system to be:
1. Real-time
Sensill aims to provide immediate insights, allowing clinicians to make rapid decisions directly at the point of care without waiting for lab results.
2. Inexpensive
The ability to identify causal pathogens at point of care—in minutes, not days—has been shown to reduce both length of stay and overall economic costs.
3. Fast
Sensill aims to analyze emitted volatile organic compounds within minutes, identifying and quantifying infectious bacteria at the point of initial diagnosis.
4. Accurate
Sensill plans to provide an accurate identification and quantification of infectious bacteria or fungi, comparable to but more efficient than traditional methods.
5. Non-invasive
The Sensill diagnostic system intends to avoid skin biopsies, making it far easier and less expensive than traditional care. It's designed to be an entirely non-invasive procedure.
6. Portable
The Sensill diagnostic system intends to be easy to carry between patients and battery-operated, making it ideal as a portable device.
7. Easy
The design of the Sensill diagnostic system is intended to seamlessly integrate into existing workflows and be easy for all health professionals to operate.
8. Quantitative
Sensill aims to provide a quantitative metabolic readout reflecting the actual level of organism burden, which can help monitor treatment effectiveness.
9. Versatile
The platform is designed to be capable of detecting metabolite signatures from any living organism, offering unparalleled versatility beyond its initial focus on skin and urine infections.
10. Patented Technology
Sensill's validated platform is protected by 17 patents, ensuring a powerful and robust new standard in diagnostics.
11. Combats Antibiotic Resistance
By providing accurate identification and minimizing broad-spectrum antibiotic use, Sensill aims to contribute to a reduction in the rate of resistance development.
12. No Calibration Required
The system is intended for on-demand use at the point of care, with no calibration required.
13. Identifies Pathogens & Subspecies
Sensill demonstrates the ability to identify and quantify bacteria, fungi, and subspecies (e.g., MRSA).
14. Companion
Sensill aims to enable companion diagnostics at the point of care, helping to close the loop in infection management.